🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

European shares rise for third straight session

Published 08/20/2019, 03:23 PM
Updated 08/20/2019, 03:30 PM
European shares rise for third straight session
UK100
-
AZN
-
PNDORA
-
STOXX
-
SX7P
-
SXAP
-

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)
Aug 20 (Reuters) - European shares rose for the third
straight session on Tuesday, building on a recovery since late
last week as British drugmaker AstraZeneca surged on results of
a late-stage study.
Shares of the drugmaker AZN.L rose 1.5% after the company
said its diabetes drug Farxiga met the main goal of the study
for the treatment of patients with heart failure. The pan-European STOXX 600 index .STOXX was up 0.1% by
0712 GMT, with London's FTSE 100 .FTSE outperforming.
Pandora A/S PNDORA.CO jumped 6.4% to the top of the STOXX
600 index on Tuesday after the Danish jewellery maker maintained
its full-year guidance. However, a fall in bank shares .SX7P and auto parts makers
.SXAP capped gains.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.